GlassScriptPhysician profile
Joseph L Perry
NPI 1952375776
$791.22
in general payments reported to CMS, 2019-2025
13 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $69.10 · 2022: $23.03 · 2023: $362 · 2024: $171 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $699.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineology INC. | $257.80 | 2023 | Optimesh Expandable Interbody Fusion System |
| Vertex Pharmaceuticals Incorporated | $110.69 | 2024-2025 | |
| Si-Bone, INC. | $105.20 | 2024-2025 | |
| Embody, INC. | $73.48 | 2021-2022 | |
| Zimvie INC. | $55.99 | 2023-2024 | |
| Depuy Synthes Sales INC. | $54.82 | 2023 | Na, Orthovisc |
| Medtronic, INC. | $30.63 | 2025 | Mazor X System |
| Highridge Medical LLC | $22.33 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Reel Surgical, INC. | $19.67 | 2024 | |
| Zimmer Biomet Holdings, INC. | $18.65 | 2021 | |
| Smith+Nephew, INC. | $14.58 | 2025 | Renasys Touch, "Acticoat 4"" X 4""", Pico 14 |
| Pacira Pharmaceuticals Incorporated | $14.32 | 2024 | Iovera, Exparel, Zilretta |
| Bioventus LLC | $13.06 | 2023 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.